Literature DB >> 24986658

Effects of several acetylated chitooligosaccharides on antioxidation, antiglycation and NO generation in erythrocyte.

Chang-Mei Zhang1, Shu-Han Yu1, Liang-Shuan Zhang1, Zhan-Yi Zhao1, Lu-Lu Dong2.   

Abstract

Three kinds of chitooligosaccharides (COS) with different degrees of deacetylation were prepared and named MD90, MD70 and MD50, respectively. Antioxidation, antiglycation and nitric oxide (NO) promotion in erythrocyte of these samples were investigated. The results showed that COS, especially MD90 had obviously inhibitory effects on oxidation and glycation. In addition, MD90 displayed stronger effect on increasing endogenous NO content than both MD70 and MD50, whose degrees of deacetylation were lower. The results indicated that amino group in COS has a certain effect on the activities of COS. As COS have a conformed activity to treat diabetes, the results of this study may be meaningful for further understanding the mechanism of the action.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antiglycation; Antioxidation; Chitooligosaccharides; Degree of deacetylation; Nitric oxide

Mesh:

Substances:

Year:  2014        PMID: 24986658     DOI: 10.1016/j.bmcl.2014.03.083

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Characterization of a novel polysaccharide isolated from Phyllanthus emblica L. and analysis of its antioxidant activities.

Authors:  Yongyu Li; Jianyan Chen; Lili Cao; Liang Li; Fang Wang; Zhengping Liao; Jianjun Chen; Shaohua Wu; Liaoyuan Zhang
Journal:  J Food Sci Technol       Date:  2018-05-24       Impact factor: 2.701

Review 2.  Can functional oligosaccharides reduce the risk of diabetes mellitus?

Authors:  Di Zhu; Qiaojuan Yan; Jun Liu; Xia Wu; Zhengqiang Jiang
Journal:  FASEB J       Date:  2019-08-15       Impact factor: 5.834

3.  Determination of the Deacetylation Degree of Chitooligosaccharides.

Authors:  Yao Jiang; Chuhan Fu; Sihui Wu; Guihua Liu; Jiao Guo; Zhengquan Su
Journal:  Mar Drugs       Date:  2017-10-25       Impact factor: 5.118

4.  Chitosan treatment abrogates hypercholesterolemia-induced erythrocyte's arginase activation.

Authors:  Gamaleldin I Harisa; Sabry M Attia; Khairy M A Zoheir; Fars K Alanazi
Journal:  Saudi Pharm J       Date:  2016-05-26       Impact factor: 4.330

5.  An Amphiprotic Novel Chitosanase from Bacillus mycoides and Its Application in the Production of Chitooligomers with Their Antioxidant and Anti-Inflammatory Evaluation.

Authors:  Tzu-Wen Liang; Wei-Ting Chen; Zhi-Hu Lin; Yao-Haur Kuo; Anh Dzung Nguyen; Po-Shen Pan; San-Lang Wang
Journal:  Int J Mol Sci       Date:  2016-08-10       Impact factor: 5.923

6.  Microbial glycolipoprotein-capped silver nanoparticles as emerging antibacterial agents against cholera.

Authors:  Geeta Gahlawat; Sristy Shikha; Baldev Singh Chaddha; Saumya Ray Chaudhuri; Shanmugam Mayilraj; Anirban Roy Choudhury
Journal:  Microb Cell Fact       Date:  2016-02-01       Impact factor: 5.328

7.  Recent Updates in Pharmacological Properties of Chitooligosaccharides.

Authors:  Ilias Marmouzi; Shahira M Ezzat; Maha M Salama; Rana M Merghany; Aisha M Attar; Ahmed M El-Desoky; Shanaz O Mohamed
Journal:  Biomed Res Int       Date:  2019-10-31       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.